Trial Profile
A Randomized Prospective Study Comparing Effects And Safety Of Sorafenib Versus Hepatic Arterial Infusion Chemotherapy For Advanced Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Aug 2019
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Cisplatin; Fluorouracil
- Indications Liver cancer
- Focus Therapeutic Use
- 01 Feb 2017 New trial record